Tang and Taghiglou [10] focused on the mechanism of action of curcumin in AD including its inhibitory effect on Aβ and tau, copper-binding ability, cholesterol-lowering ability, anti-inflammatory activity, regulation of microglia, AChE inhibition, oxidative and anti-inflammatory properties, and modification of insulin signaling pathways. The gene discussed is INS; the disease is Alzheimer disease.